Public Profile

Incepta Pharmaceuticals Ltd.

Incepta Pharmaceuticals Ltd., a leading player in the pharmaceutical industry, is headquartered in Dhaka, Bangladesh. Founded in 2003, the company has rapidly established itself as a key provider of high-quality generic medicines, active pharmaceutical ingredients (APIs), and innovative formulations across various therapeutic areas. With a strong presence in both domestic and international markets, Incepta is committed to enhancing healthcare through its diverse portfolio, which includes products in oncology, cardiology, and anti-infectives. The company is recognised for its state-of-the-art manufacturing facilities and adherence to stringent quality standards, positioning it as a trusted name in the industry. Incepta's dedication to research and development, alongside its strategic partnerships, has led to significant milestones, including the introduction of several first-to-market products. This commitment to excellence has solidified its reputation as a pioneer in the pharmaceutical landscape of Bangladesh and beyond.

DitchCarbon Score

How does Incepta Pharmaceuticals Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

10

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

Incepta Pharmaceuticals Ltd.'s score of 10 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.

44%

Incepta Pharmaceuticals Ltd.'s reported carbon emissions

Incepta Pharmaceuticals Ltd., headquartered in Bangladesh (BD), currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or climate commitments outlined. Without concrete figures or initiatives, it is challenging to assess their carbon footprint or climate strategy. However, as a player in the pharmaceutical industry, Incepta is likely aware of the growing importance of sustainability and may be exploring avenues to address climate change in line with industry standards. Further information on their emissions and commitments would be necessary to provide a comprehensive overview of their environmental impact and efforts.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Incepta Pharmaceuticals Ltd.'s primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Incepta Pharmaceuticals Ltd. is headquartered in BD, which has a rank of medium, indicating medium grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Incepta Pharmaceuticals Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

Techno Drugs Ltd.

BD
Chemicals nec
Updated about 1 month ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers